Aptevo Therapeutics Inc. (APVO) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Stay updated on Aptevo Therapeutics Inc. (APVO) stock with short-term forecast for year 2025 and long-term price prediction for 2025 - 2050. Access historical performance, see analyst ratings, and follow the latest Aptevo Therapeutics Inc. news and developments.
1 Month Prediction
$1.00 [-49.75%]
3 Month Prediction
$1.00 [-49.75%]
6 Month Prediction
$1.00 [-49.75%]
1 Year Prediction
$1.00 [-49.75%]
3 Year Prediction
$1.00 [-49.75%]
5 Year Prediction
$1.00 [-49.75%]
About Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel bispecific immunotherapies for cancer treatment. Founded in 2016 and headquartered in Seattle, Washington, Aptevo leverages its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create antibody therapies designed to improve outcomes for cancer patients.
The company's pipeline includes both clinical and preclinical candidates targeting various hematologic malignancies and solid tumors. Its lead clinical candidate, mipletamig, is a bispecific CD3xCD123 ADAPTIR molecule designed to redirect the patient's immune system to destroy leukemia cells expressing the CD123 antigen. Another clinical candidate, ALG.APV-527, is a bispecific conditional 4-1BB agonist co-developed with Alligator Bioscience.
Aptevo Therapeutics Inc. (APVO) Historical Performance
IPO Date
Aptevo Therapeutics Inc. (NASDAQ:APVO) went public on 16 February, 2016.
Change
Since inception, APVO has decreased by 100.00%. In the last 5 years, APVO has fallen from $9279.60 to $1.99, a massive -99.98% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $71192.44 and a low of $1.16.
52 Week Range
$0.942
$180.19
The current price $1.99 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
APVO Stock Price History
Based on APVO stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the APVO stock has fallen from $6023.6 - $71192.44 to $1.16 - $4.38, which is down -99.98%. Currently, the stock follows downward trend.
Here, we have calculated stock range of APVO, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $6023.6 - $71192.44 | $20039.32 | 24.6 | 1 Year Change |
| 2021 | $12812.36 - $54538.0 | $34896.18 | 116.98 | 2 Year Change |
| 2022 | $3776.96 - $9556.36 | $6630.03 | -58.78 | 3 Year Change |
| 2023 | $294.67 - $3744.4 | $1879.53 | -88.31 | 4 Year Change |
| 2024 | $4.31 - $276.76 | $69.93 | -99.57 | 5 Year Change |
| 2025 | $1.16 - $4.38 | $2.84 | -99.98 | 6 Year Change |
APVO Price Performance
6-Month Performance
APVO stock dropped by 80.79% in the last six months.
1-Year Performance
The stock has trended downwards by 92.46% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 99.97%.
5-Year Performance
In the last 5 years, the stock has gone down by 99.98%.
According to Aptevo Therapeutics Inc.'s historical data, below graph gives us the exact picture of how the APVO stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
299.67% ↑
2021
78.53% ↓
2022
70.52% ↓
2023
92.20% ↓
2024
98.54% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Aptevo Therapeutics Inc. (APVO) Financials & Stock Analysis
Market Capitalization
Aptevo Therapeutics Inc. has a market capitalization of $2.90M, which places APVO in the nano-cap category.
Fundamental Analysis
EPS: $nan (Q4), $nan (1Y)
EPS decreased nan% since last quarter, and decreased nan% since last year.
Net Income: $-6.31 M (Q4), $-24.13 M (1Y)
Net Income increased 23.74% since last quarter, and increased 38.59% since last year.
Free Cash Flow: $-5.76 M (Q4), $-23.79 M (1Y)
Free Cash Flow increased N/A since last quarter, and increased 102.77% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for APVO stock. These indicators help you understand Aptevo Therapeutics Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for APVO stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $2.07 |
| SMA50 | $3.09 |
| SMA200 | $8.58 |
| RSI | 43.36 |
| Beta | 5.75 |
SMA20 > Current Price
This signals APVO stock is in short-term bearish momentum.
SMA50 > Current Price
This signals APVO stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals APVO stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for APVO stock is Bearish. Out of all indicators, 1 indicates bullish signals, 5 signals bearish trends and 3 gives neutral trends. The APVO stock forecast was last updated on 04 April, 2025.
Aptevo Therapeutics Inc. (APVO) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to fall to $1.00 by the end of 2025, and can reach around $0.91 to $1.09 in 2026. And, the long-term forecast suggests that the stock may further drop to $0.73 - $1.24 in 2028, and $0.90 - $0.71 by 2031. So, the APVO stock shows a strong downward trend in the next several years.
Short-term APVO Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-05 | $1.00 | -49.75% |
| 2025-06 | $1.00 | -49.75% |
| 2025-07 | $1.00 | -49.75% |
| 2025-08 | $1.00 | -49.75% |
| 2025-09 | $1.00 | -49.75% |
| 2025-10 | $1.00 | -49.75% |
| 2025-11 | $1.00 | -49.75% |
| 2025-12 | $1.00 | -49.75% |
In 2025, the APVO stock price is expected to fluctuate between $1.0 and $1.0. According to the monthly forecast, the stock could drop to $1.00 by December 2024. If compared to the APVO's current price, the stock could lose -49.75% by the end of this year.
Long-term APVO Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $0.91 | $1.13 | $1.09 | -45.23% |
| 2027 | $0.53 | $1.04 | $0.49 | -75.38% |
| 2028 | $0.73 | $1.04 | $1.24 | -37.69% |
| 2029 | $0.95 | $1.12 | $0.70 | -64.82% |
| 2030 | $1.22 | $0.97 | $0.69 | -65.33% |
| 2031 | $0.90 | $1.88 | $0.71 | -64.32% |
| 2032 | $1.00 | $0.60 | $1.32 | -33.67% |
| 2033 | $1.30 | $1.35 | $0.89 | -55.28% |
| 2034 | $1.54 | $0.59 | $0.90 | -54.77% |
| 2035 | $1.68 | $0.84 | $0.75 | -62.31% |
| 2036 | $0.90 | $0.73 | $0.60 | -69.85% |
| 2037 | $1.25 | $0.72 | $0.47 | -76.38% |
| 2038 | $0.46 | $1.17 | $0.77 | -61.31% |
| 2039 | $1.05 | $0.86 | $0.88 | -55.78% |
| 2040 | $1.44 | $1.90 | $1.25 | -37.19% |
| 2041 | $1.41 | $1.03 | $1.38 | -30.65% |
| 2042 | $0.86 | $0.98 | $1.60 | -19.6% |
| 2043 | $0.77 | $0.90 | $0.85 | -57.29% |
| 2044 | $1.49 | $1.16 | $1.50 | -24.62% |
| 2045 | $1.41 | $0.68 | $1.87 | -6.03% |
| 2046 | $0.78 | $0.79 | $0.87 | -56.28% |
| 2047 | $0.96 | $1.07 | $1.02 | -48.74% |
| 2048 | $1.41 | $0.95 | $0.71 | -64.32% |
| 2049 | $1.23 | $0.90 | $0.65 | -67.34% |
| 2050 | $0.09 | $1.02 | $0.36 | -81.91% |
| 2051 | $1.26 | $1.13 | $1.81 | -9.05% |
Aptevo Therapeutics Inc. (APVO) Stock Price Prediction & Forecast 2025
At the start of 2025, the APVO stock was at $4.38. Today, it is trading at $1.99, which is -54.57% decrease from price at the beginning of the year. By the end of this year, you can expect the stock to fall to $1.00 by December 2025 with a -49.75% change.
Aptevo Therapeutics Inc. (APVO) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the APVO stock. During this period, the APVO's price is forecasted to shift from $0.91 to $0.69, which is -24.18% loss.
In 2026, the stock would possibly open at $0.91, escalates to $1.13 by mid-year, and wraps up at $1.09, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $1.22, soar to $0.97 by mid-year, and finish at $0.69, which is -65.58% change from current price.
Aptevo Therapeutics Inc. (APVO) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $0.90 to $1.25, which is up -64.34%
In 2031, we can expect APVO to fluctuate between $0.71 and $0.90, a shift indicating a -64.34% loss by year-end compared to current price. And Until 2040, APVO can likely vary from $1.25 to $1.44. By the end of 2040, the stock could record a -36.95% fall from today's stock price.
Aptevo Therapeutics Inc. (APVO) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the APVO stock can see an a downturn from $1.41 to $0.36 in this period. In 2041, the stock can experience a low of $1.03 by mid-year, closing the year at $1.38. This results in a -48.45% decrease from today.
Moving towards the end of 2050, APVO is projected to open the year at $0.09. The stock may peak to $1.02 during mid-year and finish the year at $0.36. Compared to the stock's current price, this translates to an overall loss of -82.02% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
APVO Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| CORT | Corcept Therapeutics Incorporated | - | $114.22 | 0.00% ▼ | $0.09 ▲ |
| GLTO | Galecto, Inc. | - | $6.65 | 51.83% ▲ | $32.48 ▲ |
| RNAZ | TransCode Therapeutics, Inc. | - | $1.38 | -30.31% ▼ | -27.53 ▼ |
| CRVO | CervoMed Inc. | - | $6.91 | 208.48% ▲ | $257.27 ▲ |
| SYRS | Syros Pharmaceuticals, Inc. | - | $0.14 | -4.90% ▼ | $3861.03 ▲ |
Last updated Apr 04 at 11:36 AM
APVO : Buy, Sell Or Hold?
Analyst Ratings
Based on 1 analysts, 1 rated as a strong buy, 0 recommended a buy, 0 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.So, according to analyst ratings, the recommendation for APVO stock is Buy.
Expert Analysis
According to APVO short-term and long-term forecast, Aptevo Therapeutics Inc. shares are projected to go down by 81.91%, and reach a value of $0.36 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 35.714285714285715, which signals Fear. Also, APVO has recorded 5/30 green days, which reflects a 21.73913043478261% positivity rate with a price volatility of 0.14%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that APVO stock is undervalued. So, Based on APVO prediction and analysis, it may be the best time to sell APVO stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "APVO” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.